• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Grünenthal - Articles and news items

AstraZeneca licenses gout drug Zurampic to Grünenthal

Industry news / 2 June 2016 / Victoria White, Digital Content Producer

Grünenthal has entered into a licensing agreement with AstraZeneca for the exclusive rights to Zurampic (lesinurad) in Europe and Latin America…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +